top of page
Mayur Katariya.

PROJECTS

FDA Grants Accelerated Approval to Astellas’ and Seattle Genetics’ PADCEV™ (enfortumab vedotin-ejfv) for People with Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer | I built an Analytics plaform that was used by Seagen Commercial Teams for successful launch of this drug - PADCEV in the market
.png)
Unlocking the power of data, AI & Analytics: Amgen's journey to the Lakehouse | Kerby Johnson
Building Enterprise Scale Data and Analytics Platforms at Amgen
Real World Data Analytics Platform that I helped build for Amgen won the BIOIT Award!
bottom of page





